6-[4-[2-(aminomethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidine-2-carboxamide;N-[[1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidin-2-yl]methyl]methanesulfonamide;1-[1-(2,4-dichlorophenyl)ethyl]-6-[4-(2-ethylpyrrolidin-1-yl)-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[1-(2,4-dichlorophenyl)ethyl]-6-[5-methyl-4-(2-methylpyrrolidin-1-yl)cyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile
C132H145Cl10N33O3S — CID 158057880
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[4-[2-(aminomethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidine-2-carboxamide;N-[[1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidin-2-yl]methyl]methanesulfonamide;1-[1-(2,4-dichlorophenyl)ethyl]-6-[4-(2-ethylpyrrolidin-1-yl)-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[1-(2,4-dichlorophenyl)ethyl]-6-[5-methyl-4-(2-methylpyrrolidin-1-yl)cyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile
6-[4-[2-(aminomethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidine-2-carboxamide;N-[[1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidin-2-yl]methyl]methanesulfonamide;1-[1-(2,4-dichlorophenyl)ethyl]-6-[4-(2-ethylpyrrolidin-1-yl)-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[1-(2,4-dichlorophenyl)ethyl]-6-[5-methyl-4-(2-methylpyrrolidin-1-yl)cyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile (PubChem CID 158057880) has the molecular formula C132H145Cl10N33O3S and a molecular weight of 2628.44 g/mol. Its IUPAC name is 6-[4-[2-(aminomethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidine-2-carboxamide;N-[[1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidin-2-yl]methyl]methanesulfonamide;1-[1-(2,4-dichlorophenyl)ethyl]-6-[4-(2-ethylpyrrolidin-1-yl)-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[1-(2,4-dichlorophenyl)ethyl]-6-[5-methyl-4-(2-methylpyrrolidin-1-yl)cyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile.
Molecular Properties
| Compound Name | 6-[4-[2-(aminomethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidine-2-carboxamide;N-[[1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidin-2-yl]methyl]methanesulfonamide;1-[1-(2,4-dichlorophenyl)ethyl]-6-[4-(2-ethylpyrrolidin-1-yl)-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[1-(2,4-dichlorophenyl)ethyl]-6-[5-methyl-4-(2-methylpyrrolidin-1-yl)cyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile |
|---|---|
| PubChem CID | 158057880 |
| Molecular Formula | C132H145Cl10N33O3S |
| Molecular Weight | 2628.44 g/mol |
| Exact Mass | 2621.88 |
| IUPAC Name | 6-[4-[2-(aminomethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidine-2-carboxamide;N-[[1-[4-[3-cyano-1-[1-(2,4-dichlorophenyl)ethyl]pyrazolo[3,4-b]pyrazin-6-yl]-6-methylcyclohex-3-en-1-yl]pyrrolidin-2-yl]methyl]methanesulfonamide;1-[1-(2,4-dichlorophenyl)ethyl]-6-[4-(2-ethylpyrrolidin-1-yl)-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile;1-[1-(2,4-dichlorophenyl)ethyl]-6-[5-methyl-4-(2-methylpyrrolidin-1-yl)cyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile |
| SMILES | CC1CC(c2cnc3c(C#N)nn(C(C)c4ccc(Cl)cc4Cl)c3n2)=CCC1N1CCCC1C.CC1CC(c2cnc3c(C#N)nn(C(C)c4ccc(Cl)cc4Cl)c3n2)=CCC1N1CCCC1C(N)=O.CC1CC(c2cnc3c(C#N)nn(C(C)c4ccc(Cl)cc4Cl)c3n2)=CCC1N1CCCC1CN.CC1CC(c2cnc3c(C#N)nn(C(C)c4ccc(Cl)cc4Cl)c3n2)=CCC1N1CCCC1CNS(C)(=O)=O.CCC1CCCN1C1CC=C(c2cnc3c(C#N)nn(C(C)c4ccc(Cl)cc4Cl)c3n2)CC1C |
| InChI | InChI=1S/C27H31Cl2N7O2S.C27H30Cl2N6.C26H27Cl2N7O.C26H29Cl2N7.C26H28Cl2N6/c1-16-11-18(6-9-25(16)35-10-4-5-20(35)14-32-39(3,37)38)24-15-31-26-23(13-30)34-36(27(26)33-24)17(2)21-8-7-19(28)12-22(21)29;1-4-20-6-5-11-34(20)25-10-7-18(12-16(25)2)24-15-31-26-23(14-30)33-35(27(26)32-24)17(3)21-9-8-19(28)13-22(21)29;1-14-10-16(5-8-22(14)34-9-3-4-23(34)25(30)36)21-13-31-24-20(12-29)33-35(26(24)32-21)15(2)18-7-6-17(27)11-19(18)28;1-15-10-17(5-8-24(15)34-9-3-4-19(34)12-29)23-14-31-25-22(13-30)33-35(26(25)32-23)16(2)20-7-6-18(27)11-21(20)28;1-15-11-18(6-9-24(15)33-10-4-5-16(33)2)23-14-30-25-22(13-29)32-34(26(25)31-23)17(3)20-8-7-19(27)12-21(20)28/h6-8,12,15-17,20,25,32H,4-5,9-11,14H2,1-3H3;7-9,13,15-17,20,25H,4-6,10-12H2,1-3H3;5-7,11,13-15,22-23H,3-4,8-10H2,1-2H3,(H2,30,36);5-7,11,14-16,19,24H,3-4,8-10,12,29H2,1-2H3;6-8,12,14-17,24H,4-5,9-11H2,1-3H3 |
| InChIKey | FKHDBBGJZWLJEC-UHFFFAOYSA-N |
| XLogP | 27.73 |
| TPSA | 468.43 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 26 |
| Heavy Atoms | 179 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2628.44 |
| LogP ≤ 5 | 27.73 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 34 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158057880 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.